These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30430637)

  • 1. Nivolumab PD-1 inhibitor immunotherapy associated with vulvar, perineal and perianal lichen sclerosus.
    Wernham AGH; Shah F; Velangi S
    Clin Exp Dermatol; 2019 Mar; 44(2):e22-e23. PubMed ID: 30430637
    [No Abstract]   [Full Text] [Related]  

  • 2. Genital lichen sclerosus after nivolumab.
    Miraglia E; Soda G; Giustini S
    Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342187
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.
    Page B; Borradori L; Beltraminelli H; Yawalkar N; Hunger RE
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e256-e257. PubMed ID: 28430376
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma.
    Korman AM; Tyler KH; Kaffenberger BH
    Int J Dermatol; 2017 Apr; 56(4):e75-e77. PubMed ID: 28102540
    [No Abstract]   [Full Text] [Related]  

  • 5. No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.
    Takimoto R; Otsuka A; Kaku Y; Honda T; Kabashima K
    Eur J Dermatol; 2018 Feb; 28(1):84-85. PubMed ID: 29400292
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous Fat Necrosis During Nivolumab Therapy for Metastatic Melanoma.
    Pach J; Olamiju B; Weiss S; Damsky W; Leventhal J
    JAMA Dermatol; 2021 Apr; 157(4):468-469. PubMed ID: 33688919
    [No Abstract]   [Full Text] [Related]  

  • 7. Nivolumab-associated bullous pemphigoid reactions involving multiple epitopes.
    Aoki Y; Miyagawa F; Miyashita K; Nishimura Y; Hashimoto T; Asada H
    Eur J Dermatol; 2019 Oct; 29(5):552-554. PubMed ID: 31570326
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
    Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
    J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma.
    Wada N; Uchi H; Furue M
    J Dermatol; 2017 Aug; 44(8):e196-e197. PubMed ID: 28391613
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy.
    Chin CK; Hall S; Green C; Van Hazel G; Spagnolo D; Cheah CY
    Eur J Cancer; 2019 Jul; 115():84-87. PubMed ID: 31129384
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated Adrenocorticotropic Hormone Deficiency in Melanoma Patients Treated with Nivolumab.
    Kitano S; Tatsuno K; Ishibe J; Shimauchi T; Fujiyama T; Ito T; Ogawa N; Tokura Y
    Acta Derm Venereol; 2018 Jul; 98(7):704-705. PubMed ID: 29405244
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient.
    Fujimura T; Kambayashi Y; Furudate S; Kakizaki A; Hidaka T; Haga T; Hashimoto A; Morimoto R; Aiba S
    J Dermatol; 2017 Mar; 44(3):e13-e14. PubMed ID: 27440178
    [No Abstract]   [Full Text] [Related]  

  • 13. Scleroderma-like syndrome associated with nivolumab treatment in malignant melanoma.
    Cho M; Nonomura Y; Kaku Y; Nakabo S; Endo Y; Otsuka A; Kabashima K
    J Dermatol; 2019 Jan; 46(1):e43-e44. PubMed ID: 29863795
    [No Abstract]   [Full Text] [Related]  

  • 14. Lichen sclerosus involving the vagina.
    Longinotti M; Schieffer YM; Kaufman RH
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1217-9. PubMed ID: 16260578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.
    Potter JE; Moore KA
    J Gen Intern Med; 2013 Apr; 28(4):592-5. PubMed ID: 22956445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Poliosis Following Checkpoint Inhibitor Treatment for Cutaneous Melanoma.
    Ediriwickrema LS; Liu CY; Kikkawa DO; Korn BS
    Ophthalmic Plast Reconstr Surg; 2019; 35(5):e121-e122. PubMed ID: 31373986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual skin reaction in uveal melanoma during treatment with nivolumab: extragenital lichen sclerosus.
    Veronesi G; Scarfì F; Misciali C; Tartari F; Melotti B; Patrizi A; Dika E
    Anticancer Drugs; 2019 Oct; 30(9):969-972. PubMed ID: 31205068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
    Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
    Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma.
    Denny J; Chong H; Akhras V
    Clin Exp Dermatol; 2018 Apr; 43(3):354-356. PubMed ID: 29222829
    [No Abstract]   [Full Text] [Related]  

  • 20. A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints.
    Feist J; Murray A; Skapenko A; Schulze-Koops H
    Arthritis Rheumatol; 2019 Nov; 71(11):1823. PubMed ID: 31297971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.